News Releases 2002

12-18-2002 MDS Inc. Concludes US$311 Million Private Debt Placement
12-18-2002 MDS Will Defend Itself Against Ministry of Environment Charges
12-17-2002 MDS Pharma Services Expands Drug Development and Manufacturing Capabilities Through Services Alliance with Patheon
12-12-2002 MDS Reports Fourth Quarter Fiscal 2002 Results
12-12-2002 MDS Inc. Fourth Quarter F2002 Management's Discussion and Analysis of Operating Results and Financial Position
12-12-2002 MDS Inc. - Q4 Earnings Announcement - December 12, 2002
12-10-2002 MDS Inc. Announces Private Debt Placement
11-12-2002 MDS responds to below-market ''mini-tender'' offer
10-29-2002 MDS Nordion's MAPLE 1 Reactor Authorized for Low-power Commissioning
10-28-2002 MDS Pharma Services Advances Bioanalysis Capabilities
10-23-2002 MDS Pharma Services Strengthens Bioanalytical Capabilities in Europe
10-03-2002 MDS Pharma Services Expands Early Clinical Research Facility in Phoenix, Arizona
09-19-2002 MDS Reports Third Quarter 2002 Results
09-19-2002 MDS Inc. Thrid Quarter F2002 Management's Discussion and Analysis of Operating Results and Financial Position
07-11-2002 MDS Nordion Receives Approval for New Radiotherapy Dose Calculation Software
07-10-2002 MDS Offers Improved Parathyroid Test Across Canada
06-26-2002 MDS Inc. and ARUP Laboratories Form New Collaborative Alliance
06-26-2002 MDS Nordion forms new business unit focused exclusively on oncology software solutions
06-19-2002 MDS Inc. Normal Course Issuer Bid
06-14-2002 MDS Confirms that Water Testing is Accurate
06-13-2002 MDS Laboratory Services Statement
06-12-2002 New Small Molecule Development Program Offered by MDS Pharma Services
06-12-2002 MDS Nordion meets growing demand for new cancer therapies with expansion of radiopharmaceutical manufacturing facility
06-11-2002 MDS Sciex Recognized With Technology Transfer Award
06-07-2002 MDS Pharma Services' Central Clinical Lab in Beijing First Lab in China To Receive College of American Pathologists' (CAP) Accreditation
06-06-2002 Applied Biosystems/MDS Sciex announce Canadian introduction of new system for protein and metabolite analysis at BIO 2002
06-05-2002 MDS Reports Solid Performance in Second Quarter
06-05-2002 MDS Inc. Second Quarter F2002 Management's Discussion and Analysis of Operating Results and Financial Position
05-29-2002 Applied Biosystems Introduces New System for Protein and Metabolite Analysis At American Society of Mass Spectrometry Conference
05-24-2002 Injunction Entered Against Micromass in Applied Biosystems/MDS Sciex Patent Suit
05-21-2002 MDS Nordion Introduces Cost-Effective HDR Brachytherapy Device for Cancer Treatment
05-13-2002 MDS Proteomics Named to the Red Herring 100
05-09-2002 MDS Proteomics and Thermo Finnigan to Collaborate on Design of Next-Generation Technology to Dramatically Accelerate Proteomics-Based Drug Discovery
05-08-2002 MDS Pharma Services Expands Early Clinical Research Facility in New Jersey As Part of Global Expansion Plans
04-23-2002 MDS Pharma Services Enters Into Multi-Year, Global Agreement With AstraZeneca To Provide Customized Pharmacology Screening
04-22-2002 MDS Pharma Services Introduces Integrated 'Metabolism Resource' Service
04-18-2002 MDS Pharma Services Establishes Drug Development Programs Capability
04-04-2002 MDS Sciex awarded $17.5 million for large-scale Genome Canada project
03-19-2002 MDS Pharma Services Expands Capabilities at Early Clinical Research Facility in Hamburg
03-15-2002 Applied Biosystems/MDS Sciex Win Patent Suit Against Micromass Business Editors/Health & Medical Writers
03-14-2002 MDS Inc. Announces Cash Dividend
03-07-2002 MDS Reports Solid Start For 2002
03-07-2002 MDS Inc. First Quarter F2002 Management's Discussion and Analysis of operating results and financial position
03-06-2002 MDS Inc. to Announce First Quarter Results and Hold Annual General Meeting
03-01-2002 MDS Proteomics Develops Litmus Test for Drug Efficacy; Study Offers Pharmaceutical Industry New Way to Select Drug Candidates by Identifying ``On/Off'' Switches for Proteins
02-25-2002 DrugMatrix Development Milestone Announced by MDS Pharma Services and Iconix
02-13-2002 MDS Pharma Services Announces Global Expansion Plans for 2002
02-05-2002 MDS Proteomics Acquires Top Quality cDNA Collection; Deal with Kazusa DNA Research Institute Fuels MDS Proteomics' Drug Discovery Technology Platform